Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Times New Jersey.
Press releases published on September 22, 2025
Soup Capital Exchange Upgrades Trading Engine to Process Over 500,000 Orders per Second
Denver, CO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Soup Capital LTD, a fintech innovator based in Denver, today announced a major upgrade to its flagship product, Soup Capital Exchange, unveiling a next-generation trading engine capable of processing over 500, …
Genius Group to host Genius Future Summit on October 2-3, 2025
SINGAPORE, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced the final speaker lineup for the Genius Future Summit that the …
Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM
CINCINNATI, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) ("Onconetix" or the “Company”) a commercial stage biotechnology company focused on the research, development and commercialization of innovative solutions for men’s health and …
CEA Industries Board Authorizes $250 Million Stock Buyback Program
New York, Sept. 22, 2025 (GLOBE NEWSWIRE) -- CEA Industries Inc. (Nasdaq: BNC), (“BNC” or the “Company”), the world’s leading corporate holder of BNB and prominent industry advocate of BNB adoption, today announced that its Board of Directors has …
SAIC Announces Proposed Offering of $500.0 Million in Senior Notes
RESTON, Va., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC) (“SAIC”), a premier Fortune 500 technology integrator driving our nation's digital transformation across the defense, space, civilian, and intelligence …
Intellia Therapeutics to Present Longer-Term Data from the Ongoing Phase 1 Clinical Trial of Nexiguran Ziclumeran (nex-z) for the Treatment of Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy
CAMBRIDGE, Mass., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that longer-term data from the …
Xtract One Selected by Manor Independent School District to Strengthen Security Long-Term Across District Campuses
TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its Xtract One Gateway (“Gateway”) system has been selected by Manor Independent School District (“Manor …
Plus Therapeutics Announces Additional $1.9 Million Advance Payment from CPRIT
Non-dilutive payment is part of $17.6 million award granted for the Company’s leptomeningeal cancer targeted radiotherapeutic development program HOUSTON, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical …
BridgeBio to Present Additional Cardiovascular Outcomes Data from ATTRibute-CM at the HFSA Annual Scientific Meeting 2025
PALO ALTO, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced today that one late breaking clinical trials oral …
XOMA Royalty Declares Quarterly Preferred Stock Dividends
EMERYVILLE, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA Royalty’s Series A and Series B Cumulative Preferred Stock …
Aptose and Hanmi Pharmaceutical Extend Loan Agreement to Continue Development of Tuspetinib in Triplet Therapy for AML
SAN DIEGO and TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat …
Global Nurse Call Systems Market to Reach USD 4.0 Billion by 2029 | MarketsandMarkets™
Delray Beach, FL, Sept. 22, 2025 (GLOBE NEWSWIRE) -- The global nurse call systems market, valued at US$2.2 billion in 2023, stood at US$2.5 billion in 2024 and is projected to advance at a resilient CAGR of 10.2% from 2024 to 2029, culminating in a …
Starpharma Announces a Collaboration and License Agreement with Genentech
MELBOURNE, Australia, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Starpharma (ASX: SPL, US OTC: SPHRY), an innovative Australian biotechnology company, today announced the signing of a collaboration and license agreement with Genentech, a member of the Roche Group, …
Avalo Therapeutics Appoints Kevin R. Lind to Board of Directors
WAYNE, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today announced the appointment …
Gogo announces EASA STC for Gogo Galileo HDX antenna for Bombardier Global aircraft, granted to QCM Design
BROOMFIELD, Colo., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Gogo (NASDAQ: GOGO) announced today that Switzerland-based QCM Design has received European Union Aviation Safety Agency (EASA) approval for a Gogo Galileo HDX Antenna Supplemental Type Certificate (STC …
MBX Biosciences Announces Once-Weekly Canvuparatide Achieved Primary Endpoint in Phase 2 Trial with 63% Responder Rate at 12 Weeks; 79% Responder Rate at 6 Months in Open-Label Extension
Statistically significant responder rate achieved at 12 weeks with zero contribution from rescue therapy (PRN) and further improvement sustained in open-label extension (OLE) Positive findings in bone and kidney biomarkers All patients completed the 12- …
Aeluma Announces Closing of Oversubscribed Public Offering with $25.4 Million Gross Proceeds
GOLETA, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ: ALMU) (“Aeluma” or “the Company”), a transformative semiconductor company specializing in high-performance and scalable technologies, today announced the closing of its previously …
Reitar Logtech Partners with NEXX to Launch Global Strategic Cooperation
First Project to Establish a Smart E-commerce Fulfillment Center in Qatar Set to Commence Full Operations by Year-End HONG KONG, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Reitar Logtech Holdings Limited (NASDAQ: RITR) (“Reitar” or “The Company”), a Nasdaq listed …
Crystal Art Gallery Increases Ecommerce Fulfillment 5x with Descartes Sellercloud™
ATLANTA, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that California-based Crystal Art Gallery, a leading global omnichannel supplier …
Sierra Space Achieves Perfect CMMC Level 2 Score with eSHARE as Strategic Partner
WALTHAM, Mass., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Sierra Space met CMMC Level 2 with a perfect score—110 out of 110 controls satisfied—demonstrating an uncompromising commitment to cybersecurity and regulatory compliance. Strategic Partnership with eSHARE …